Metabolic disorders and their correction in chronic allergic dermatoses
co-authored with Shmelkova E.S., Kalashnikova V.S.
Качук Ю.В. Метаболические нарушения и их коррекция при хронических аллергодерматозах / Ю.В. Качук, Е.С. Шмелькова, В.С. Калашникова // Клінічна імунологія. Алергологія. Інфектологія. – 2012. – № 1. – С. 60-62
In clinical practice, chronic allergic dermatoses (CAD), which include atopic dermatitis (AD) and eczema, occupy a special place. They are one of the most important problems of practical medicine. According to foreign authors, about 25% of patients who seek consultative help every day suffer from one or another allergic disease with skin manifestations. On average, 6–15% of the world's population suffer from allergic dermatoses; in some regions of Ukraine the incidence of allergic dermatoses is over 50% of all skin pathology, which is an important medical, social and economic problem. [Н.И. Ильина, Е.С. Феденко. Кожные проявления аллергии. Физиология и патология иммунной системы, 2004, № 2, с. 125-134, Кутасевич Я.Ф. Современные возможности совершенствования наружного лечения дерматологических заболеваний. //Украинский Журнал дерматологии и венерологии №4, грудень 2007.-С.7-10., Рыжко п.п, Рощенюк Л.В. Современные аспекты лечения аллергодерматозов]
CAD are inflammatory skin diseases that can significantly affect patients' quality of life, given their frequent localization on exposed areas of the skin, marked itching and an unpredictable, relapsing course [Короткий НГ, Тихомиров АА, Таганов АВ, Каражас МВ. Современные аспекты этиологии, патогенеза, клиники и фармакотерапии атопического дерматита. Лечащий врач. 2000;10: 42-47; Anderson RT, Rajagopalan R. Effects of Allergic Dermatosis on heal-related quality of life. Curr Allergy Asthma Rep. 2001; 1:309-15]. The marked increase in the number of these diseases is due to a number of factors: environmental pollution, especially in industrialized countries, constant contact at home and at work with a variety of chemicals (household chemicals, cosmetics, building materials, metals, synthetic materials in clothing and footwear). The rise in the incidence of allergic dermatoses is undoubtedly also promoted by the use of large quantities of drugs, including vitamins and food additives, canned food and fast food. Pathology of the gastrointestinal tract is a significant factor in the development of CAD. No less important a role is assigned to hereditary predisposition to allergy, especially in patients with AD. The development of eczema is promoted by stress, pathology of the digestive organs, changes in the endocrine glands, diseases of the neuroimmune system and metabolic disorders, as a result of which an allergic inflammatory skin reaction forms in eczema.
The etiology and pathogenesis of CAD remain largely unclear. According to current concepts, the fundamental pathogenetic mechanism of allergic dermatoses is systemic allergic inflammation with active manifestation in the skin. Allergy is a pathological form of immune system response, as a result of which the body's own cells and tissues are damaged. In the realization of the allergic response in skin diseases, great importance is attached to reaginic reactions and disturbances in the cell-mediated arm of immunity.[ Общая аллергология Т.1. Под. ред.Г.Б.Федосеева.–Санкт–Петербург,2001 г., с.42–382 ] The commonality of the pathogenetic mechanisms underlying CAD makes them very similar clinically as well. The clinical picture of these diseases is characterized by extremely pronounced inflammatory skin changes, especially during exacerbation. In the lesions there are marked edema, bright hyperemia, micro- and macrovesiculation, and oozing with subsequent formation of crusts or scale-crusts. Objective changes are, as a rule, accompanied by severe itching, burning or tingling of the skin. In the chronic relapsing course of allergic dermatoses, persistent clinical symptoms can lead to social isolation, reduced daily activity and loss of working capacity, and significantly worsen patients' quality of life[Белоусова Т.А. Современные подходы к наружной терапии аллергодерматозов. Materia Medica, 2002, №3–4.с.60–73 ]
In recent years, particular attention in the development and pathogenesis of these diseases has been given to the study of markers of metabolic syndrome, which, in the opinion of a number of authors, especially influence the course of CAD. It is assumed that the development of pathological processes in CAD is not limited to skin involvement but leads to disturbances in the function of other organs and systems of the body, as well as to metabolic changes in the body. [Беловол А.Н, Береговая А.А., Штыров И.Н. Хронические системные дерматозы на фоне метаболического синдрома. Вісник національного медичного університету. – 2010. – № 14(2). - С.364-369] At present, the significance of lipid metabolism and lipid peroxidation in the development of inflammatory allergic skin reactions, including in the pathogenesis of AD and eczema, is beyond doubt.[ Шмелькова Е.С. Процессы перекисного окисления липидов и антиоксидантная система при атопическом дерматите // Вісн. морської медицини. – 1999. – № 3 (7). – С. 59-60., Рябова О.А. Нарушение липидного обмена у больных экземой // Дерматологія та венерологія. – 2002.- 4(18).- С.38-39.] As is known, lipid metabolism significantly affects the physiological functions of the body's cell membranes, the activity of membrane-bound enzymes, hormones and mediators of local inflammation. Changes in the quantitative and qualitative composition of blood lipids give rise to various metabolic and structural disturbances, lipid peroxidation processes are activated, and interleukin synthesis is impaired. According to the results of studies by a number of authors, dyslipidemia is observed in patients with eczema, which undoubtedly leads to a change in the rheological properties of the blood and, as a consequence, to impaired microcirculation, which helps to sustain inflammation in the skin. Hypertriglyceridemia may be caused both by increased synthesis of both endogenous and other triglycerides in the liver and by activation of lipolysis. The decrease in phospholipid levels is probably due to intensified lipid peroxidation.[Рябова,2002]
Diagnosis and treatment at the Institute
Get a consultation
…………………..LPO in AD…………
As is known, the decrease in the activity of regenerative processes in allergic dermatoses (AD, eczema) is often associated with the accumulation of intermediate products of free-radical lipid oxidation, which are able to inhibit proliferative processes in the skin [Беловол] . It is known that between metabolic syndrome and some lesions of the skin and its appendages the risk of developing metabolic processes is higher [Верещака В.В. Молекулярні основи патогенезу старечої в’ялості шкіри // Досягнення молодих вчених-дерматовенерологів: матер.наук.-практ. конф., 2006р.: тез.доп. – К., 2006 – С.27-29] As a result of oxidative stress, noted in the literature in AD[4], the amount of superoxide anion increases. Nitric oxide (NO) is one of the strongest natural antioxidants precisely because of its ability to bind to the superoxide anion, which leads to the destruction of free NO, the development of a hypoxic state and, possibly, vascular dysfunction. Endotheliopathy can lead to changes in the microcirculatory bed (a combination of spasm of the afferent vessels with increased blood viscosity, reduced blood flow velocity, impaired transcapillary exchange and hypoxia), which are important in the development and course of AD. Superoxide dismutase (SOD) competes with NO for the superoxide anion in the body; it is the only antioxidant enzyme that breaks the chains of oxygen-dependent free-radical reactions and protects NO from degradation. Glutathione peroxidase (GP) takes part in the antiradical defense system; it reduces hydrogen peroxide to water and dissolves lipid and fatty acid hydroperoxides. By breaking down lipid hydroperoxides, GP thereby regulates the production of arachidonic acid and reduces inflammation. In our studies we found a decrease in the content of NO2- in both serum and erythrocytes ( p < 0.01) and an increase in the level of NO3- in the blood serum of AD patients (p < 0.05) compared with the corresponding indicators of the control group. The activity of SOD (p < 0.01) and GP (p > 0.05) in the patients' erythrocytes proved to be reduced relative to that in healthy individuals. The changes found indicate substantial disturbances in the oxidative pathway of metabolism of L-arginine, from which NO is formed, weakening of antiradical defense along the enzymatic chain in AD patients, and the need to use endothelial and antioxidant agents in therapy.
Microcirculation disorders also play an important role in the pathogenesis of AD [5, 7]. The combination of spasm of the afferent vessels with increased blood viscosity leads to blockage of the microvascular bed by erythrocyte conglomerates of the sludge-phenomenon type, as a result of which blood flow velocity falls significantly, transcapillary exchange is impaired and hypoxia develops. The main factors determining dysfunction of the microhemocirculatory bed are restructuring of the endothelium, disturbance of the tone and permeability of various microvessels and of the rheological properties of the blood, and increased permeability of the histohematic barrier.
Endothelial dysfunction is a predictor and an invariable attribute of the pathogenesis of a number of CAD; it is an imbalance between the factors that help maintain homeostasis of the vascular wall and those that regulate the various functions of the vascular endothelium [6]. The results of our studies of the L-arginine – nitric oxide (NO) system and of the activity of the enzymatic arm of the antioxidant system indicate the existence of endothelial dysfunction in AD patients, manifested by decreased NO synthase activity and NO content and increased levels of endoperoxides and reactive oxygen species [8].
Disturbances of blood macroelement metabolism take part in the formation of many pathological conditions and serve as one of the obligatory links in their pathogenesis [13, 17]. The metabolic role of magnesium (Mg) is determined by its participation as a cofactor in more than 300 enzymatic reactions. The Mg-ATP complex ensures the work of the K–Na pump of cell membranes and activates adenylate and guanylate cyclase, hexo-, creatine-, phosphofructo- and protein kinase, thus participating in practically all metabolic processes of the body [12]. Mg affects the endothelium, which plays a key role in vascular homeostasis, including through the production of NO and participation in the control of platelet aggregation. In addition, Mg is a natural and physiological antagonist of calcium (Ca) [1]. It has been established that Mg and Ca in various tissues can act both as synergists and as antagonists. Antagonism between the action of these two cations has been proven with respect to vascular smooth muscle.
The main pathochemical and pathophysiological mechanisms of allergic inflammation, both in the skin and in mucous membranes, are calcium-dependent: release of mediators from mast cells, hypersecretion of mucus by the bronchial glands, contraction of smooth muscle cells, etc. It is known that even a short-term increase in the intracellular concentration of Ca initiates redistribution of Mg, K and Na ions [2, 13].
The importance of studying the content of Mg and Ca and of correcting them in AD is determined by their simultaneous participation in maintaining the integrity and permeability of cytoplasmic membranes, vascular tone and vasodilation, the secretion of hormones, cytokines, etc. [1, 15].
Mg preparations are known to be able to influence the state of microcirculation and the vascular endothelium and to restore impaired endothelium-dependent relaxation [21].
In our studies, changes in blood macroelement levels were noted only in patients with moderate and severe AD. In patients with moderately severe dermatosis, the Mg content in serum and erythrocytes decreased significantly (p < 0.05) and the erythrocyte Ca/Mg ratio increased (p < 0.01) compared with the values in healthy individuals. In severe AD, deviation of almost all studied parameters was noted: a marked decrease in total Mg in serum and erythrocytes (p < 0.01), a decrease in total Ca, Ca2+ (p < 0.05) and especially intracellular Ca (p < 0.01), and a sharp increase in the erythrocyte Ca/Mg ratio (p < 0.01). The serum Ca/Mg ratio in patients tended to decrease but did not differ from that in the control group.
Disorders of macroelement balance in AD patients, manifested by hypomagnesemia, a decrease in the intracellular Mg level, moderate hypocalcemia and an increase in intracellular Ca content (only in severe dermatosis), may cause disturbances of microcirculation, of the synthesis and functioning of the L-arginine - NO system, of constitutive NO synthase activity and of lipid peroxidation, as well as an increase in serum C-reactive protein, which is also associated with metabolic disorders.
We corrected such disturbances by using a complex therapy method with the prescription of metabolic drugs. A method of treating AD patients was developed using, along with traditional therapy, the drugs «Glutargin» (0.25 g 3 times a day in mild and moderate severity, 0.5 g 3 times a day in severe course, for 15 days), «Tri-vi plus» (1 tablet a day for patients under 14 years, 1 tablet 2 times a day for patients over 14 years, for 21 days) and «Magnerot» (1.0 g 3 times a day during the first week of treatment, then 0.5 g 3 times a day for the following 3 weeks in moderate severity of the disease, 5 weeks in severe AD).
The use of the drugs «Glutargin», «Tri-vi plus» and «Magnerot» in complex treatment contributed to an increase in the nitrite anion content in serum and erythrocytes by 1.5-1.6 times, a decrease in the activity of inducible NO synthase by 1.7-1.8 times, arginase by 1.4-1.7 times and superoxide dismutase by 1.9-2.2 times, in serum urea by 1.3-1.7 times, in uric acid by 1.6-2.1 times, an increase in serum and erythrocyte magnesium (by 1.4-1.5 times), a decrease in erythrocyte calcium by 1.4 times, and in the erythrocyte calcium/magnesium ratio by 2.9-3.0 times (p < 0.05-0.001). The use of metabolic agents in the complex treatment of AD patients made it possible to achieve positive results (clinical recovery, marked improvement and improvement) in 92.6 % of patients, to shorten treatment time 1.5 times and to reduce the number of relapses 2.2 times compared with traditional therapy. [Качук Ю.В. Комплексне лікування хворих на атопічний дерматит з урахуванням механізмів регуляції синтезу оксиду азоту, стану антиоксидантного захисту і макроелементів. Автореф. …на к.м.н, Харков, 2007]
Conclusions: Thus, the study of markers of metabolic disorders and their correction in CAD is relevant today and promising for the study of the pathogenesis of these diseases and for optimizing treatment, especially of severe and torpid forms of CAD.